baber/WOPTO huggingface dataset:
Patent NZ-587712-A (NZ)
Title: Method for producing a mixture of bacteriophages and the use thereof in the therapy of antibiotic-resistant staphylococci
Inventor: MULLER ROBERT F
IPC: A61P31/04
Filed: 2009-03-13
Abstract: Disclosed is a method for producing a mixture of bacteriophages, wherein at least two different bacteriophage strains have been reproduced separately, wherein a staphylococcus strain is grown in an preculture with each of strains of a bacteriophage that can lyse staphylococci and is then further reproduced in a main culture, and is then purified, and the different strains are then mixed, characterised in that the mixture of bacteriophages used comprises at least two different serotypes of bacteriophages that lyse specifically bacteria of the species Staphylocuccus whereby the mixture of bacteriophages contains the bacteriophage MP13.3 having the accession number DSM 18722 and the bacteriophage KP3 having the accession number DSM 18723 and in that the bacterial strain that is used for the reproduction of the bacteriophages is a methicillin-sensitive strain of Staphylococcus aureus.
Patent NZ-588123-A (NZ)
Title: (1S,5S)-3-(5,6-Dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
Inventor: BUCKLEY MICHAEL J
IPC: C07D213/74
Filed: 2004-05-20
Abstract: Disclosed is a pharmaceutical composition for treating amyotrophic lateral sclerosis or premenstrual syndrome which comprises a therapeutically effective amount of (1S,5S)-3-(5,6-dichloro-pyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane or a pharmaceutically acceptable salt thereof. Further disclosed is a pharmaceutical composition comprising a therapeutically effective amount of (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane or a pharmaceutically acceptable salt thereof, in combination with a pharmaceutically acceptable carrier, wherein the composition is in a solid dosage form or a liquid dosage form. Also disclosed is (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane (L)-tartrate and (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane p-toluenesulfonate.
Patent NZ-590385-A (NZ)
Title: Signatures and determinants associated with metastasis and methods of use thereof
Inventor: CHIN LYNDA
IPC: G01N33/574
Filed: 2009-06-26
Abstract: Disclosed is method for assessing a risk of development of a metastatic tumor in a sample isolated from a subject comprising: a. measuring the levels of two or more DETERMINANTS selected from the group consisting of ACP5, ANLN, ASF1B, BRRN1, BUB1, CDC2, CENPM, DEPDC1, ELTD1, EXTl, FSCNl, HCAP-G, HMGB1, HMGB2, HOXA1, HSF1, ITGB3BP, KIF20A, KIF2C, KNTC2, MCM7, MTHFD2, NASP, PLVAP, PTP4A3, RNF2, SPAG5, TGM2, UBE2C, UCHL5, and VSIG4 in the sample from the subject, b. measuring a clinically significant alteration in the levels of the two or more DETERMINANTS in the sample to a reference value, wherein the alteration indicates an increased risk of developing a metastatic tumor in the subject.
Patent NZ-593819-A (NZ)
Title: Large scale pancreatic islet purification
Inventor: MATSUMOTO SHINICHI
IPC: A61K35/39
Filed: 2009-12-23
Abstract: Disclosed is a method of isolating pancreatic islets comprising : creating a continuous density gradient in a vessel comprising at least 100 millilitres with a bend tube that reduces convection currents that disrupt the gradient; loading a solution comprising pancreatic islets in the density gradient; centrifuging the vessel wherein the pressure on the pancreatic islets is less than 50Pa; and isolating the pancreatic islets from the gradient.
Patent NZ-596705-A (NZ)
Title: Medicament identification system for multi-dose injection devices
Inventor: SMITH CHRIS
IPC: A61M5/00
Filed: 2010-05-28
Abstract: A dose setting mechanism for a drug delivery device with a cartridge, comprises a body 35 and a dial sleeve 40 that is operably connected with the body, where the dial sleeve has an outer surface that contains an indicia 42 to identify a medicament and where the indicia is hidden from view when a zero dose is set. At least part of the indicia 42 on the outer surface of the dial sleeve 40 is exposed when a dose greater than zero is set.
Patent NZ-598661-A (NZ)
Title: Low frequency glatiramer acetate therapy
Inventor: KLINGER ETY
IPC: A01N37/44
Filed: 2010-08-19
Abstract: Disclosed is the use of glatiramer acetate for the manufacture of a medicament comprising a 40 mg dose of glatiramer acetate for treating a patient who is suffering from relapsing remitting multiple sclerosis or who has experienced a first clinical episode and is at high risk of developing clinically definite multiple sclerosis, wherein the medicament is adapted for administration in a regimen of three subcutaneous injections over a period of seven days with at least one day between each subcutaneous injection.
Patent NZ-603578-A (NZ)
Title: Mobile station, radio base station, and communication control method
Inventor: ISHII HIROYUKI
IPC: H04W24/10
Filed: 2011-05-12
Abstract: 603578 Disclosed is a mobile station for communicating with a radio base station using two or more carriers. The two or more carriers include a carrier in a continuous reception state and a carrier in a discontinuous reception state. The mobile station includes a first communicating unit configured to perform communications on the carrier in the continuous reception state. The mobile station also includes a second communicating unit configured to perform communications on the carrier in the discontinuous reception state. The first communicating unit treats intervals before and after an on-duration of the carrier in the discontinuous reception state as measurement gaps.
Patent NZ-603717-A (NZ)
Title: Suture line administration technique using botulinum toxins
Inventor: BLUMENFELD ANDREW M
IPC: A61K38/48
Filed: 2009-03-31
Abstract: 603717 Disclosed is a use of a botulinum toxin in the manufacture of a medicament for treating a patient suffering from depression associated with a headache, wherein the medicament is formulated for administration to a nerve located in the vicinity of at least one suture line of the patient’s skull.
Patent NZ-607435-A (NZ)
Title: Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin b1 receptor
Inventor: DOODS HENRI
IPC: C07D403/12
Filed: 2011-08-19
Abstract: Disclosed are disubstituted tetrahydrofuranyl compounds of general formula (I), wherein the variables R, Rand X are defined in the specification, the enantiomers, diastereomers, mixtures and salts thereof, especially the physiologically acceptable salts thereof with organic or inorganic acids or bases, which have valuable properties, to methods for producing the same, to the drugs containing the pharmacologically active compounds and to the production and use thereof. Examples of such compounds are (S)-6-oxo-1,6-dihydro-pyridazine-4-carboxylic acid-{ 3-[2-fluoro-4-(4-methoxy-2-trifluoromethyl-phenylamino)-benzylcarbamoyl]-tetrahydrofuran-3-yl} -amide and (S)-5-amino-N-{ 3-[4-(4-methoxy-2-trifluoromethyl-phenylamino)-benzylcarbamoyl]tetrahydrofuran-3-yl} -nicotinamide.
Patent NZ-607721-A (NZ)
Title: A pregnancy test system
Inventor: GARGIULO GAETANO
IPC: A61D17/00
Filed: 2011-08-12
Abstract: 607721 A pregnancy test system (10) includes a carrier (14) carrying a plurality of sensors arranged in a fixed relationship relative to one another. A signal processing circuit processes data sensed by the sensors and outputs a data signal representative of the pregnancy status of an animal being examined. A support arrangement (24) supports the carrier (14) in a desired position relative to the animal. A positioning mechanism (26) is associated with the carrier (14) for positioning the carrier (14) at the desired position relative to the animal.
Patent NZ-610012-A (NZ)
Title: Compositions and methods of treating pulmonary hypertension
Inventor: BELARDINELLI LUIZ
IPC: C07D317/46
Filed: 2011-10-14
Abstract: This disclosure relates to the use of a therapeutic effective amount of ambrisentan ((2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid - A) and tadalafil ((6R-trans)-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino[1’,2’:1,6] pyrido[3,4-b]indole-1,4-dione - B) in the manufacture of a medicament for treating pulmonary hypertension in a human patent, where the effect of the combination treatment is greater than the sum of the individual treatments of ambrisentan and tadalafil. The components are in a weight ratio of ambrisentan to tadalafil from about 1:1 to about 1:10. The disclosure also relates to the use of this combination for the treatment of endothelin-induced vasoconstriction, hypertension, myocardial infarction, angina pectoris, acute kidney failure, renal insufficiency, cerebral vasospasms, cerebral ischemia, subarachnoid haemorrhages, asthma, atherosclerosis, intravascular coagulation, restenosis after angioplasty, hypertension caused by ischemia or intoxication, kidney failure caused by ischemia or intoxication, Raynaud’s syndrome and asthmatic airway conditions.
Patent NZ-616758-A (NZ)
Title: Hsp90 inhibitors
Inventor: SUN WEILIN
IPC: C07D473/40
Filed: 2012-04-05
Abstract: The disclosure relates to purine derivative compounds as inhibitors of Heat Shock Protein 90 (HSP90) of general Formula (IA) and (IB), wherein the substituents are as described in the specification. Compositions comprising an effective amount of a Compound of Formula (IA) or (IB), and methods to treat or prevent a condition, such as cancer which overexpresses Her-kinases, comprising administering to an patient in need thereof a therapeutically effective amount of a Compound of Formula (IA) or (IB) or a pharmaceutically acceptable salt thereof. The disclosure further relates to compounds of Formula (IA) and (IB) in which X2 is a leaving group such as trialkyl tin or SN(CH2CH2(CF2)5CF3)3 for introducing a radiolabeled atom, such as 124I or 131I, and to methods of using such compounds in the preparation of radiolabeled compounds, particularly for use in imaging.
Patent NZ-616767-A (NZ)
Title: Apparatus and method of detecting movement of objects within the abdominal and/or pelvic region
Inventor: FAUSETT M BARDETT
IPC: A61M25/09
Filed: 2012-03-15
Abstract: Aspects of an apparatus and method for detecting movement of an object includes a base and a projection member extending between a first second ends, wherein the first end is attached to the base. Further included is a support member at the second end of the projection member, and a guide wire carried by the support member and having a substantially fixed length, wherein the guide wire is movable between a first position and a second position in conjunction with movement of an object. Also included is a sensor located a substantially fixed distance along a path of the guide wire from the support member, wherein the sensor detects movement of the guide wire between the first second positions. Additionally included is a feedback unit in communication with the sensor, wherein the feedback unit is configured to generate feedback corresponding to the detected movement.
Patent NZ-627941-A (NZ)
Title: Hatching fluid enzymes and uses thereof
Inventor: LEREN HANS KRISTIAN
IPC: A61K8/64
Filed: 2010-11-30
Abstract: Disclosed is a pharmaceutical or cosmetic composition comprising: i) an acidic polypeptide comprising an amino acid sequence as set forth in SEQ ID No. 2 or a sequence which is at least 70% identical to the sequence, or a functional portion of any of the sequence, wherein the portion comprises at least 30 amino acids; (ii) an acidic polypeptide comprising an amino acid sequence as set forth in SEQ ID No. 3 or a sequence which is at least 70% identical to the sequence, or a functional portion of any of the sequence, wherein the portion comprises at least 30 amino acids; (iii) an acidic polypeptide comprising an amino acid sequence as set forth in SEQ ID No. 4 or a sequence which is at least 70% identical to the sequence, or a functional portion of any of the sequence, wherein the portion comprises at least 30 amino acids; and/or (iv) one or more nucleic acid molecules encoding a polypeptide as set forth in any of (i) to (iii) above or a complementary sequence thereof, and one or more pharmaceutically or cosmetically acceptable excipients and/or diluents; wherein the sequences are as defined in the specification. Also disclosed is the use of the polypeptides to treat a condition or disorder of the skin of a non-human animal wherein the skin is abnormally dry, the horny layer of the skin is abnormally thickened or the skin has a pigmentation disorder.
Patent NZ-630668-A (NZ)
Title: Bracket for mounting curtain tracks
Inventor: WAITAI RANA
IPC: A47H1/144
Filed: 2014-09-09
Abstract: Disclosed is a bracket (1) for mounting a curtain track (22). The bracket comprises a first attachment portion (15). The first attachment portion provides a first mounting position (as shown) and a second mounting position for the curtain track. In the first mounting position the curtain track rests on the bracket, and in the second mounting position the bracket is secured to the bracket. The bracket may comprise a first member and an extension member, wherein the first member is fixedly attached to a mounting surface and the extension member is slidably partially housed in the first member. The extension member may comprise the attachment portion, such arrangement would allow adjustment of the distance between the curtain track and the surface. The bracket may further comprise a second attachment means for mounting a second curtain track. The second attachment part may comprise teeth on an upper portion of the bracket for inter-engagement with a second curtain track.
Patent NZ-700254-A (NZ)
Title: Breast wrap
Inventor: DE VERE PHILIPPA
IPC: A61F13/14
Filed: 2012-01-18
Abstract: The disclosure relates to a breast wrap for absorbing fluid secreted from a wearer’s breasts. In one embodiment the breast wrap comprises a panel of material, means for fastening the panel in a continuous band, one or more absorbent regions on a first side of the panel, and first and second adjustment means independently operable to adjust the tightness of the band along first and second adjustment regions proximate the top and bottom of the band respectively. In use, the wrap is configured to wrap around a wearer’s chest and substantially cover the wearer’s breasts with the one or more absorbent regions covering the wearer’s nipples and the first and second adjustment regions positioned above and below the wearer’s breasts respectively. In another embodiment, the breast wrap comprises one or more absorbent panels removably attached to a first side of the first panel and, in use, the one or more absorbent panels cover the wearer’s nipples.
Patent NZ-703784-A (NZ)
Title: Pre-stressing tendon separation device
Inventor: GÖPFERT HEINRICH
IPC: B23D29/00
Filed: 2013-07-08
Abstract: The invention relates to a device (1) for the separation of pre-stressing tendons consisting of steel, particularly pre-stressing tendons for pre-stressed concrete structures such as, for example, wind turbine towers, said device being configured to separate a bundle that consists of a plurality of pre-stressing tendons, in one procedure. According to the invention, the device comprises a housing (3), a cutting body (29) arranged within the housing, and a plurality of passage openings (13) corresponding to the plurality of pre-stressing tendons that extend through the housing, said passage openings each having a slot (23) running through them that is designed to receive the cutting body (29), and said cutting body having one or more cutting edges (43) and being able to be driven, in the housing, in a movable manner relative to the passage openings in a cutting direction such that the cutting edge or edges pass fully across the passage openings.
Patent NZ-710698-A (NZ)
Title: A fabric roll up core for carrying sheet material
Inventor: FOY SUZANNE ELIZABETH
IPC: B65H75/28
Filed: 2015-08-04
Abstract: A fabric roll up core for carrying rolls of sheet material such as ground covers or canopy sheet materials including netting materials, used in agriculture or horticulture, such as bird, insect, hail, shade, wind barrier netting materials, comprises a profile formed in an outer surface that assists in maintaining the sheet material on the fabric roll up core when rolling the sheet material onto the fabric roll up core and which may be effective to work with roll up drive means. The core may be formed in one piece or as multiple connected parts.
Patent NZ-721493-A (NZ)
Title: Crystalline salt form of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
Inventor: GUDE MARKUS
IPC: A61P25/00
Filed: 2014-12-02
Abstract: The invention relates to a crystalline form of (S)-(2-(6-chloro-7-methyl-1 H-benzo[d]imidazol- 2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone hydrochloride, processes for the preparation thereof, pharmaceutical compositions containing said crystalline form, and its use as medicament, especially as orexin receptor antagonist.
Patent NZ-727664-A (NZ)
Title: Composition for detection and treatment of bed bugs
Inventor: OLSON JOELLE F
IPC: A01N31/00
Filed: 2015-06-08
Abstract: The present disclosure provides for a composition and method for attracting bed bugs to a trap or to a location where an insecticide or pesticide is present, or to a trap or a location where a bed bug infestation can be detected. The present disclosure provides for a composition for attracting bed bugs that includes one or more of methyl diethanolamine (MDEA), monoethanolamine (MEA), diethanolamine (DEA), triethanolamine (TEA), and dimethyl trisulfide (DMTS); a carrier; and optionally one or more amides selected from oleamide, octanamide, nonanamide, and laurylamide; urea, biuret, or triuret; and one or more aliphatic fatty acids. The present disclosure further provides for a method for treating an article by applying the composition to the article, where the article comprises a device for trapping or detecting bed bugs or a device for treating a bed bug infestation.
Patent NZ-733010-A (NZ)
Title: Lipid-encapsulated gas microsphere compositions and related methods
Inventor: ROBINSON SIMON
IPC: A61K49/22
Filed: 2015-12-28
Abstract: The invention provides, inter alia, improved lipid formulations used to generate lipid-encapsulated gas microspheres, and methods of their use. The lipid-encapsulated gas microspheres comprising DPPA, DPPC and PEG5000-DPPE and perfluorocarbon gas, in a non-aqueous solution comprising propylene glycol and/or glycerol, wherein the non-aqueous mixture comprises equal to or less than 5% w/w water.
Patent NZ-738150-A (NZ)
Title: System and method for identification of individual animals based on images of the back
Inventor: BORCHERSEN SØREN
IPC: A01K29/00
Filed: 2016-06-30
Abstract: The present disclosure relates to a system and a method for identification of individual animals based on images, such as 3D-images, of the animals, especially of cattle and cows. When animals live in areas or enclosures where they freely move around, it can be complicated to identify the individual animal. In a first aspect the present disclosure relates to a method for determining the identity of an individual animal in a population of animals with known identity, the method comprising the steps of acquiring at least one image of the back of a preselected animal, extracting data from said at least one image relating to the anatomy of the back and/or topology of the back of the preselected animal, and comparing and/or matching said extracted data against reference data corresponding to the anatomy of the back and/or topology of the back of the animals with known identity, thereby identifying the preselected animal. The method and system can be used to monitor feed intake, such as feed intake for dairy cows as well as health status.
Patent NZ-738383-A (NZ)
Title: Distributed optical fiber identification system and method for identification of seepage conditions of a hydraulic structure and base thereof
Inventor: SU HUAIZHI
IPC: G01N15/08
Filed: 2016-01-08
Abstract: Common distributed optical fiber temperature systems measure the temperature on the basis of the property that Raman back-scattering light is modulated by the temperature. However, these systems have the disadvantages that the pulse width is uneasy to adjust, the spatial resolution is low, and the signal to noise ratio is poor. For example, distributed optical fiber Raman temperature sensors using a pulse coding technology are directed to a single-mode optical fiber, and need to adopt complicated coding and decoding technologies in order to improve the signal to noise ratio as well as the signal extraction and resolving ability of the system, which greatly increases the operation difficulty and the design complexity of equipment. The present invention discloses a distributed optical fiber identification system and method for seepage conditions of a hydraulic structure and a base thereof. The system comprises a single-mode optical fiber having an automatic control heat source specifically produced for seepage measurement, an optical path coupler and a synchronous controller, the synchronous controller is connected to a mode locked laser, a polarization beam splitter, an isolator, a grating pair, a diffraction grating, a reflector, a beam splitter, a nonlinear crystal, a spectrometer and a Michelson interferometer, the output end of the Michelson interferometer is connected to the optical path coupler, the output end of the optical path coupler is connected to a detector and a second optical splitter respectively, the detector is connected to a digital signal processor, the second optical splitter is connected to the digital signal processor through an amplifying circuit, and the digital signal processor is connected to the synchronous controller and a collector respectively.
Patent NZ-740380-A (NZ)
Title: A composite geometry structure for the absorption and dissipation of the energy generated by an impact and a safety helmet comprising said structure.
Inventor: ABDOLAHIAN ALESSIO
IPC: A42B3/06
Filed: 2016-09-16
Abstract: Cyclists, in particular those riding in urban traffic, skaters, roller-bladers, skateboarders need helmets capable of mainly serving two purposes: efficiently absorbing and dissipating energy generation following an impact; and occupying little space, so that they can be easily put away in a rack sack or bag when not being used. The invention attempts to address these two purposes by providing a composite geometry structure 1 for the absorption and dissipation of the energy generated by an impact comprising a plurality of hollow cells 2 adjacent and stably connected to each other. On each cell 2 there are identified one or more arc elements 3 (see Figure 2) which develop starting from two juxtaposed areas of the same perimeter edge 4 of the cell, such arc elements 3 being configured to be elastically deformed. Each cell is polyhedric-shaped.
Patent NZ-740956-A (NZ)
Title: Reversing the effects of the tumor microenvironment using chimeric cytokine receptors
Inventor: LEEN ANN
IPC: C12N5/00
Filed: 2012-04-05
Abstract: An immune system cell comprising a chimeric cytokine receptor comprising a cytokine-binding exodomain and a signal transducing endodomain, wherein (a) the exodomain comprises an IL-13 cytokine binding exodomain and an IL-7 signal transducing endodomain. Further discloses treatment of cancer.